A patient with a suspected ischemic stroke presents with a National Institutes of Health Stroke Scale (NIHSS) score of 12, right-sided hemiparesis, expressive aphasia, and blood glucose of 210 mg/dL. What is the priority nursing intervention while awaiting CT scan results?

C) Monitoring vital signs and maintaining airway patency.

A) Administering insulin to lower blood glucose to normal levels.

B) Initiating thrombolytic therapy immediately.

C) Monitoring vital signs and maintaining airway patency.

D) Administering antihypertensive medication to rapidly decrease blood pressure.

A patient arrives at the emergency department with a suspected stroke. The nursing assessment reveals right-sided hemiparesis, expressive aphasia, anisocoria, and a blood pressure of 172/96 mmHg. Given the initial findings and the need for rapid intervention, which nursing action should be prioritized to prevent further neurological damage while awaiting CT scan results?

D) Maintain head-of-bed elevation at 30 degrees and ensure airway patency.

A) Prepare for immediate administration of thrombolytic therapy.

B) Administer IV antihypertensive medication to lower blood pressure.

C) Monitor blood glucose levels closely and administer insulin as needed.

D) Maintain head-of-bed elevation at 30 degrees and ensure airway patency.

A patient with an acute ischemic stroke in the left middle cerebral artery territory has been administered intravenous tPA. Following treatment, the patient exhibits increased confusion and a decrease in responsiveness. Which of the following actions should the nurse prioritize?

B) Prepare the patient for an immediate CT scan to rule out hemorrhagic transformation

A) Administer a bolus of IV fluids to improve cerebral perfusion

B) Prepare the patient for an immediate CT scan to rule out hemorrhagic transformation

C) Decrease the dose of antihypertensive medication to prevent further hypotension

D) Increase the frequency of neurological assessments to monitor changes

A patient with an acute ischemic stroke in the left middle cerebral artery is receiving intravenous tPA therapy. After treatment, the patient exhibits increased confusion and a decrease in responsiveness, with a GCS score of 11. Which of the following actions should the nurse prioritize to address this change in the patient's condition?

B) Perform a neurological assessment and notify the healthcare provider immediately.

A) Increase the infusion rate of tPA to ensure clot dissolution.

B) Perform a neurological assessment and notify the healthcare provider immediately.

C) Administer additional antihypertensive medication to lower blood pressure further.

D) Discontinue all medications to prevent further complications.

A patient who recently received thrombolytic therapy for an ischemic stroke is now exhibiting right-sided hemiparesis, slurred speech, and a decreased ability to follow commands. The repeat CT scan shows mild cerebral edema but no new bleeding. Which nursing intervention should be prioritized to manage the patient's cerebral edema and prevent further neurological deterioration?

C) Administer mannitol as prescribed to reduce intracranial pressure

A) Increase the patient's fluid intake to promote hydration

B) Position the patient in a flat supine position to enhance cerebral perfusion

C) Administer mannitol as prescribed to reduce intracranial pressure

D) Apply continuous positive airway pressure (CPAP) to improve oxygenation

A patient is experiencing cerebral edema following thrombolytic therapy with tPA. Which of the following nursing interventions would be most appropriate to manage the cerebral edema and prevent further neurological deterioration?

D) Elevating the head of the bed to 30 degrees

A) Administering a hypertonic saline solution

B) Placing the patient in a supine position

C) Restricting fluid intake to prevent overload

D) Elevating the head of the bed to 30 degrees

A patient with a cerebrovascular disorder presents with a decreased level of consciousness, right-sided paralysis, and hyponatremia. The healthcare team has initiated hypertonic saline and adjusted mannitol dosing. Which clinical finding would most indicate improvement in the patient's condition following these interventions?

A) Improvement in speech clarity

B) Blood pressure stabilizing at 120/80 mmHg

C) Serum sodium level increasing to 135 mEq/L

D) Decrease in creatinine level to 1.2 mg/dL

A patient with a cerebrovascular disorder is experiencing worsening neurological status, including decreased level of consciousness and complete right-sided paralysis. His serum sodium level is 128 mEq/L and creatinine is 1.5 mg/dL. Which intervention should the nurse prioritize to address the patient's current condition?

B) Initiate continuous infusion of hypertonic saline.

A) Administer a rapid bolus of isotonic saline.

B) Initiate continuous infusion of hypertonic saline.

C) Increase the dose of mannitol.

D) Restrict fluid intake to prevent further edema.

A patient with a recent ischemic stroke is being treated with hypertonic saline for hyponatremia. The serum sodium level has increased to 132 mEq/L, but the patient exhibits persistent hypertension and tachycardia. Which of the following nursing interventions should be prioritized to prevent further complications in this patient?

C) Monitor neurological status and prepare for a repeat CT scan.

A) Administer a beta-blocker to manage the patient's tachycardia.

B) Encourage oral fluid intake to promote renal function.

C) Monitor neurological status and prepare for a repeat CT scan.

D) Increase the rate of hypertonic saline infusion to rapidly correct sodium levels.

A patient with a recent ischemic stroke is receiving hypertonic saline and mannitol as part of their treatment plan. The patient's serum sodium level has increased to 132 mEq/L, and there is modest improvement in neurological function. However, the patient continues to exhibit tachycardia and elevated blood pressure. What is the most appropriate nursing intervention at this time?

C) Conduct frequent neurological assessments to monitor for signs of osmotic demyelination syndrome.

A) Administer a beta-blocker to address the elevated heart rate and blood pressure.

B) Increase the rate of hypertonic saline infusion to further improve neurological function.

C) Conduct frequent neurological assessments to monitor for signs of osmotic demyelination syndrome.

D) Discontinue mannitol to prevent further increases in blood pressure.

cerebrovascular disorder - Nursing Case Study

Pathophysiology

• Primary mechanism: Cerebrovascular disorders often result from the interruption of blood flow to the brain, commonly due to arterial blockage by atherosclerotic plaques or emboli. This leads to ischemia, causing oxygen and nutrient deprivation in brain tissue, and potentially resulting in neuronal cell death.

• Secondary mechanism: Hemorrhagic events, such as those caused by hypertension-induced vessel rupture, result in blood leakage into or around brain tissue. This increases intracranial pressure and further compromises blood flow, exacerbating brain tissue damage.

• Key complication: Both ischemic and hemorrhagic events can lead to edema and increased intracranial pressure, potentially causing herniation, significant neurological deficits, or, if untreated, death.

Patient Profile

Demographics:

68-year-old male, retired school teacher

History:

• Key past medical history: Hypertension, type 2 diabetes, hyperlipidemia

• Current medications: Lisinopril, Metformin, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Sudden onset of weakness on the right side of the body

• Key symptoms: Slurred speech, difficulty walking, headache, dizziness, blurred vision

• Vital signs: Blood pressure 168/94 mmHg, heart rate 98 bpm, respiratory rate 22 breaths per minute, temperature 37.3°C (99.1°F), oxygen saturation 93% on room air

Section 1

Initial Assessment Findings:

Upon arrival at the emergency department, the patient underwent a comprehensive neurological assessment. The National Institutes of Health Stroke Scale (NIHSS) was performed, revealing a score of 12, indicating moderate stroke severity. The patient displayed significant right-sided hemiparesis, with decreased strength graded at 2/5 in the right upper and lower extremities. He also exhibited expressive aphasia, struggling to articulate words but demonstrating comprehension through nodding and gestures. Pupillary assessment showed anisocoria, with the right pupil slightly larger than the left and sluggish in response to light. His Glasgow Coma Scale (GCS) score was 13, reflecting mild confusion and verbal disorientation, yet he remained able to follow simple commands.

Vital signs showed persistent hypertension with a blood pressure of 172/96 mmHg, suggesting inadequate control of underlying hypertensive state, which could exacerbate ischemic damage or indicate impending hemorrhagic transformation. Blood glucose was elevated at 210 mg/dL, pointing to suboptimal diabetes management, potentially contributing to endothelial dysfunction and increased risk of stroke progression. An urgent CT scan of the brain without contrast was ordered to differentiate between ischemic and hemorrhagic stroke, considering his history and presentation.

The initial assessment highlights the need for rapid intervention to minimize ongoing neurological damage. The combination of poorly controlled hypertension and diabetes, along with the current neurological findings, suggest a complex interplay of factors requiring immediate attention. The clinical team must prioritize stabilizing the patient's blood pressure and glucose levels while awaiting imaging results to guide further management, potentially involving thrombolytic therapy if ischemia is confirmed.

Section 2

New Diagnostic Results:

As the clinical team awaited the CT scan results, they began addressing the patient's hypertension and hyperglycemia, recognizing these as potential exacerbating factors in his cerebrovascular disorder. The patient's blood pressure was cautiously lowered utilizing intravenous antihypertensive medications, targeting a gradual reduction to prevent further cerebral ischemia. Concurrently, insulin therapy was initiated to manage his elevated blood glucose levels, aiming to bring them down to a safer range, while ensuring close monitoring to avoid hypoglycemia.

The CT scan results arrived, revealing an acute ischemic stroke in the territory of the left middle cerebral artery, with no evidence of intracranial hemorrhage. This confirmed the absence of a hemorrhagic stroke, making the patient a candidate for thrombolytic therapy, given that he presented within the appropriate time window. The team promptly initiated intravenous tissue plasminogen activator (tPA) to dissolve the clot and restore cerebral blood flow, fully aware of the critical balance between therapeutic benefits and the risk of bleeding.

As the team continued to monitor the patient, they observed a subtle yet concerning change in his neurological status. The patient began exhibiting increased confusion and a decrease in responsiveness, with his GCS score dropping to 11. This prompted an urgent re-evaluation of his condition, including a repeat assessment of vital signs and a review of potential causes such as hemorrhagic transformation, cerebral edema, or complications related to tPA administration. The evolving situation required the healthcare team to employ clinical reasoning to swiftly determine the underlying cause and adjust the management plan accordingly, ensuring the patient's safety and optimizing outcomes in a rapidly changing clinical scenario.

Section 3

As the healthcare team conducted a detailed reassessment of the patient's condition, they noted several critical changes in his clinical status. His vital signs showed a blood pressure of 160/95 mmHg, heart rate of 88 beats per minute, respiratory rate of 22 breaths per minute, and oxygen saturation of 92% on room air. Neurological examination revealed that the patient had developed right-sided hemiparesis, increased slurring of speech, and a further decline in his ability to follow commands. These findings were indicative of worsening cerebral ischemia or potential complications from the administered thrombolytic therapy.

In parallel with the physical assessment, laboratory results were reviewed. The patient's serum glucose was stabilized at 140 mg/dL, while his coagulation profile showed a prolonged activated partial thromboplastin time (aPTT), suggesting an increased risk for bleeding. Given the potential for hemorrhagic transformation post-tPA, the team prioritized an urgent repeat CT scan of the brain. The repeat imaging revealed mild cerebral edema but no new bleeding, alleviating immediate concerns of a hemorrhagic event. However, the edema indicated potential further compromise of cerebral perfusion.

Recognizing the critical nature of these developments, the team focused on managing the cerebral edema to prevent further neurological deterioration. They initiated measures to optimize cerebral perfusion, including maintaining adequate hydration, elevating the head of the bed to 30 degrees, and administering mannitol to reduce intracranial pressure. The patient's fluid and electrolyte balance were closely monitored, as was his neurological status, to detect any additional changes promptly. This meticulous and dynamic approach underscored the importance of clinical reasoning in adapting the treatment plan to address new complications and optimize patient outcomes in the context of an evolving cerebrovascular event.

Section 4

As the healthcare team continued to monitor the patient's condition, they observed a change in his status that warranted immediate attention. The patient's neurologic examination showed a further decrease in his level of consciousness; he was now difficult to arouse and responded only to painful stimuli. His speech was almost unintelligible, and his right-sided hemiparesis had progressed to complete paralysis. Concurrently, his vital signs revealed a concerning trend: his blood pressure had increased to 175/100 mmHg, his heart rate spiked to 96 beats per minute, and his respiratory rate rose to 26 breaths per minute. His oxygen saturation remained at 92% on room air, despite the interventions aimed at optimizing cerebral perfusion.

Given these alarming changes, the team urgently reviewed the patient's latest laboratory results. The serum sodium level was noted to be low at 128 mEq/L, suggesting hyponatremia, which could exacerbate cerebral edema and contribute to the patient's declining neurological status. Additionally, the patient's renal function tests indicated a slight elevation in creatinine levels to 1.5 mg/dL, raising concerns about renal impairment possibly related to the administration of mannitol. This necessitated a careful reevaluation of the fluid management strategy, balancing the need to reduce cerebral edema while avoiding further renal compromise.

In response to these developments, the healthcare team adjusted the treatment plan. They initiated hypertonic saline to address the hyponatremia and potentially alleviate cerebral edema. Simultaneously, they reviewed and adjusted the dosing of mannitol to mitigate its impact on renal function. The patient's fluid intake was carefully calculated to ensure optimal hydration without exacerbating edema. Continuous monitoring of the patient's neurological status, vital signs, and laboratory parameters was emphasized to quickly identify any further complications and to guide ongoing therapeutic decisions. This dynamic management approach highlighted the critical role of clinical reasoning in navigating the complexities of an evolving cerebrovascular disorder, with the ultimate goal of stabilizing the patient and improving outcomes.

Section 5

As the healthcare team continued to implement the revised treatment plan, they closely monitored the patient's response to the interventions. Over the next several hours, there were subtle yet significant changes in the patient's status. The administration of hypertonic saline appeared to have a positive impact on the patient's neurologic function. There was a modest improvement in his level of consciousness; he began to respond to verbal stimuli, albeit slowly, and could follow simple commands with some delay. However, his speech remained slurred, and the complete paralysis of the right side persisted, indicating sustained damage to the affected cerebral hemisphere.

Concurrently, the laboratory results showed a gradual correction of the serum sodium level, which increased to 132 mEq/L, indicating an effective response to the hypertonic saline. This improvement in electrolyte balance was encouraging but required ongoing monitoring to prevent rapid overcorrection, which could lead to osmotic demyelination syndrome. Renal function was also reassessed, and the creatinine level stabilized at 1.4 mg/dL, suggesting that the adjusted mannitol dosing was mitigating further renal impairment. Despite these positive developments, the patient still exhibited tachycardia with a heart rate of 98 beats per minute and elevated blood pressure at 170/95 mmHg, necessitating consideration of additional interventions to manage these hemodynamic parameters.

As the team continued to evaluate the patient's progress, they remained vigilant for potential new complications. The persistent elevation in blood pressure, despite initial therapeutic adjustments, raised concerns about secondary complications such as hemorrhagic transformation of the initial ischemic stroke or the development of concurrent cardiac issues. A repeat CT scan was ordered to assess for any intracranial changes, and a cardiology consultation was considered to explore the underlying causes of the sustained hypertension and tachycardia. This ongoing assessment and adaptation of the care plan underscored the importance of dynamic clinical reasoning and the need to anticipate and address emerging challenges in the management of complex cerebrovascular disorders.